MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy

Primer Autor
Salazar, Luis A.
Co-autores
Saavedra, Kathleen
Leal, Karla
Saavedra, Nicolas
Prado, Yalena
Paez, Isis
Ubilla, Carmen G.
Rojas, Gabriel
Título
MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy
Editorial
MDPI
Revista
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Lenguaje
en
Resumen
The treatment of hypercholesterolemia is mainly based on statins. However, the response to pharmacological therapy shows high inter-individual variability, resulting in variable effects in both lipid lowering and risk reduction. Thus, a better understanding of the lipid-lowering mechanisms and response variability at the molecular level is required. Previously, we demonstrated a deregulation of the microRNA expression profile in HepG2 cells treated for 24 h with atorvastatin, using a microarray platform. In the present study, we evaluated the expression of hsa-miR-17-5p, hsa-miR-20a-5p and hsa-miR-106a-5p in hypercholesterolemic patients before and after atorvastatin treatment and in HepG2 cells treated for 24 h with atorvastatin The miRNA hsa-mir-20a-5p was repressed after atorvastatin treatment in hypercholesteremic subjects and in HepG2 cells in culture. Repression of hsa-mir-20a-5p increased LDLR gene and protein expression in HepG2 cells, while hsa-mir-20a-5p overexpression reduced LDLR gene and protein expression.
Tipo de Recurso
artículo original
Description
This research was funded by Fondecyt-Chile (Grant numbers 3160567 and 1171765), Direccion de Investigacion of the Universidad de La Frontera (Grant number DI19-0094), and ANIDChile Doctoral Scholarship number 21181008.
doi
10.3390/ijms23095022
Formato Recurso
PDF
Palabras Claves
microRNA
statin
hypercholesterolemia
cardiovascular diseases
atorvastatin
DENSITY-LIPOPROTEIN CHOLESTEROL
CORONARY-ARTERY-DISEASE
HEPATOCELLULAR-CARCINOMA
CARDIOVASCULAR-DISEASE
CHILEAN SUBJECTS
EXPRESSION
STATINS
CELLS
BIOMARKERS
MIR-17-5P
Ubicación del archivo
Categoría OCDE
Bioquímica y Biología Molecular
Química
Multidisciplinar
Materias
microARN
estatina
hipercolesterolemia
enfermedades cardiovasculares
atorvastatina
COLESTEROL-LIPOPROTEÍNA DE DENSIDAD
ENFERMEDAD-ARTERIAL-CORONARIA
CARCINOMA-HEPATOCELULAR
ENFERMEDAD-CARDIOVASCULAR
SUJETOS CHILENOS
EXPRESIÓN
ESTATINAS
CÉLULAS
BIOMARCADORES
MIR-17-5P
Título de la cita (Recomendado-único)
MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy
Identificador del recurso (Mandatado-único)
artículo original
Versión del recurso (Recomendado-único)
version publicada
License
CC BY 4.0
Condición de la licencia (Recomendado-repetible)
CC BY 4.0
Derechos de acceso
acceso abierto
Access Rights
acceso abierto
Referencia del Financiador (Mandatado si es aplicable-repetible)
ANID-FONDECYT 3160567
ANID-FONDECYT 1171765
UFRO DI19-0094
ANID 21181008
ANID FONDECYT 3160567
ANID FONDECYT 1171765
Id de Web of Science
WOS:000794627400001
Revisa las metricas alternativas de Almetrics
Revisa las citaciones de Dimensions